Kays Medical reveals a return to profit

After reporting almost £900,000 in pre-tax losses in its previous year, Liverpool medical supplier, occupational health and logistics specialist Kays Medical reveals a return to profit. Tony McDonough reports

Kays Medical chief executive Ben Ludzker in the Speke logistics facility

 

Liverpool family firm Kays Medical has returned to profit amid “extremely competitive” trading.

Based in Speke in the south of the city, Kays is a supplier of medical equipment and pharmaceutical products and provides first aid training, occupational health services and third-party logistics.

It began life as a high street pharmacy in Liverpool in the 1970s. It still operates three pharmacies in the city under a separate division. In the 1980s it diversified into a specialist supplier of medical products, equipment and pharmaceuticals.

In 2022 the company started building a 33,000 sq ft warehouse next to its headquarters in Speke. It offers third-party logistics services to other businesses that need to store and distribute products as quickly and efficiently as possible.

This expansion was supported by a £2.4m loan from Liverpool City Region Combined Authority which helped support the creation of 30 jobs.

Kays has posted its accounts for the 12 months to March 31, 2025. They reveal a rise in revenues of more than 11% to £16.3m. Pre-tax profits of £12,783 compared to pre-tax losses of £873,036 in the previous year.

READ MORE: Brake disc maker reports rocketing revenues

Writing in the annual report, chief executive and majority shareholder Ben Ludzker, said: “Despite the slow growth in the UK-wide economy, sales grew by 11.2% in the year. Growth was particularly driven by the group’s occupational health and logistics divisions.

“The growth, combined with cost focus, contributed to a significantly improved financial performance in the year.

“The directors believe that the business is now in a stable condition and while trading conditions remain extremely competitive, profitability since the end of the financial year remains at a similar level to the 2025 year end.”

featured
Comments (0)
Add Comment